What is the purpose of this trial?
This study will examine the safety and effectiveness of oxaliplatin in combination with TAS-102 (TAS-OX) for treatment of patients with metastatic colorectal cancer whose cancer has progressed or recurred after FOLFOX chemotherapy.
Yale Cancer Center
Dates: 08/19/2016 - 07/31/2019
Last Updated: 12/20/2017
Study HIC#: 1605017852